字級縮小
字級縮小
字級放大
字級放大

CDIB Healthcare Ventures Ltd.

Asset under management:NT$1.75bn
Investment strategy focuses on pharmaceuticals, medical device, services, channels, and other healthcare-related industries.
As Taiwan’s healthcare industry ecosystem is forging, and the government is clearly throwing its weight behind the sector, Taiwan-listed healthcare stocks are outperforming. In response to the trend, CDIB has integrated the resources of China Development Financial (CDF) to establish CDIB Capital Healthcare Ventures with asset under management totaling NT$1.75bn (ca. US$ 54.2mn)**. The investment strategy focuses on pharmaceuticals, medical device, services, channels, and other healthcare-related industries, while targeting sub-sectors that are innovative, regionally integrated, and closely related to Greater China’s domestic demand growth. Representatives from leading sector players are invited to become strategic shareholders of CDIB Capital Healthcare Ventures, in order to build up a long-term and in-depth partnership.
 
 
Note**:US/NT exchange rate: 32.29 as of 30 June, 2016
 
CONTACT US
Taipei
TEL:+886-2-2767-3668
FAX:+886-2-2767-7008
No. 125, section 5, Nanjing East Road, Songshan District, Taipei City